CIR On MoCRA Product Listing: FDA Should Refine Categories For Optimal Data Collection

Cosmetic product/ingredient listing required by new cosmetics regulations will be a boon for CIR, which has conducted its ingredient reviews to date based on limited, voluntary data reporting. Adding new product classifications and subcategories to the US FDA’s listing system could provide needed insight into dry shampoo and other product formats and help identify potential for incidental inhalation risks.

• Source: Shutterstock

Cosmetic Ingredient Review is weighing in on the US Food and Drug Administration’s draft guidance on cosmetic facility registration and product listing, highlighting “significant opportunities to increase [product] category specificity,” which it says would help the group better evaluate cosmetic ingredient safety.

Traditionally, CIR’s ingredient assessments have relied on data reported by industry to the agency on a voluntary basis, which provides an incomplete picture of an ingredient’s true use in the...

More from Regulation

More from Policy & Regulation